Drug Type Small molecule drug  | 
Synonyms  | 
Target  | 
Action antagonists  | 
Mechanism Dopamine reuptake inhibitors, Histamine receptor antagonists  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhasePendingDiscovery  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Attention Deficit Disorder With Hyperactivity | Discovery | United States   | - | |
| Cognition Disorders | Discovery | United States   | - | |
| Obesity | Discovery | United States   | - | 





